Despite advances in understanding the molecular mechanisms involving the development and progression of diabetic nephropathy, such as advanced glycation end-products, protein kinase C, and transforming growth factor-β (TGF-β) [2], certain effective therapeutic strategies remain to be established. The gene discussed is TGFB1; the disease is diabetic kidney disease.